Cypherpunk Technologies Inc (CYPH)

I sold yesterday pre-market when I realized how serious the breach was. There was no way for ZEC to recover from this and therefore CYPH was going down.

I think CYPH will perform RS which wouldn’t be awful. They can then dilute at higher prices without killing the stock with dilution. If/when ZEC recovers CYPH will be in a good position to move higher.
JMO. I will wait this out for awhile.

If ZEC moves to recent highs and then to $700 where does CYPH trade?
If ZEC drops back to $500 and then back to $400’s due to failed support, then what?
People are saying head and shoulders on the chart.
Some are saying if it breaks $640 then it will run.
Coin flip I guess is what I should do because I have no clue.
Bitcoin and ETH were hit hard yesterday but ZEC up over 10%. Strange times.
Good luck in trading.

Btw I have a few Cyph shares. No Zec.

Yes but zec has a positive outlook so im holding both my coins and this ticker for a little bit

You might be right if they stop ATM selling.
Short squeeze would be nice.
Stock is a crap roll. Good luck.

It’s going to go parabolic in my opinion. I keep buying below 2. I have a few zec which is up 300% in 6 weeks.  
This cypherpunk is going to be up up and away soon. In my opinion and not investment advice.  

ZEC at $613
ZCSH $45 up 9% today
CYPH $1.13 barely up 3.5%

CYPH really should be at $1.40 or higher. Company keeps selling shares from ATM which is really stopping the stock from moving higher. What a shame. Just let it run finally.

2 major concerns for me right now. RS announcement and that huge $200 million ATM.
Both could really put some lid on this stock even though Zcash is making another run to $600.
Any other stock would be at $2 at this moment.
I will need to rethink my investment here. Maybe just get into ZCSH instead.

Cypherpunk Technologies Reports First Quarter 2026 Financial ResultsMay 14, 2026 7:05 AM
PR Newswire (US) CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the first quarter ended March 31, 2026."Since the start of 2026, Cypherpunk has advanced the mission to become a leading privacy technology company with a digital asset treasury strategy focused on Zcash by making our first privacy technology investment and increasing our treasury holdings to 314,185.70 ZEC," said Douglas E. Onsi, President and CEO of Cypherpunk Technologies. "At AACR 2026, our Leap Therapeutics subsidiary presented a new DKK1 biomarker assay developed to support the selection of patients likely to benefit from sirexatamab therapy, along with the positive outcomes from our DeFianCe colorectal cancer study generated in patients with high DKK1 levels. In addition, sirexatamab received Fast Track designation from the FDA in May 2026.""Privacy-protecting assets and related technologies will be critical in the increasingly digital and AI driven world. Our $5 million investment in Zcash Open Development Labs (ZODL), the core developers of the Zcash Network and Zodl, the leading Zcash wallet, reflects our commitment to supporting the Zcash ecosystem and to building innovative companies that make the promise of private digital money a reality," said Will McEvoy, Chief Investment Officer of Cypherpunk.Cypherpunk Highlights:Increased Zcash treasury holdings to 314,185.70 ZECFrom the last update on April 15, 2026 through May 13, 2026, Cypherpunk purchased an additional 10,279.30 ZEC for $5 million at an average purchase price of $486.41 per ZEC.As of May 13, 2026, Cypherpunk held a total of 314,185.70 ZEC at an average purchase price of $337.86, representing approximately 1.88% of the total circulating supply of the Zcash network.ZEC is a digital currency that can be transmitted over a peer-to-peer payment system. Zcash uses a cryptographic method called "zero-knowledge proofs" to allow users to engage in financial transactions while maintaining greater privacy.Invested $5 million into Zcash Open Development Labs (ZODL)In March 2026, Cypherpunk expanded its holdings with a $5 million investment in ZODL, alongside key investors including a16z, Winklevoss Capital, Coinbase, Paradigm, Chapter One, David Friedberg, Balaji Srinivasan, and others. This marked Cypherpunk's first technology investment outside of ZEC. ZODL, which houses the top Zcash wallet, Zodl, aims to make Zcash easier to use with continued development of the wallet and support of the Zcash protocol.Launched new website and investor dashboard at cypherpunk.comThe Company launched its new website and investor dashboard at cypherpunk.com. The dashboard provides shareholders with direct visibility into the Company's key metrics, ZEC holdings, other privacy investments, and Zcash network metrics.Leap Therapeutics Subsidiary Highlights:Sirexatamab received Fast Track designation from FDAIn May 2026, the U.S. Food and Drug Administration (FDA) granted Fast Track designation to sirexatmab in combination with fluoropyrimidine plus oxaliplatin- or irinotecan-based chemotherapy and bevacizumab, for the treatment of patients with DKK1-high metastatic colorectal cancer whose disease has progressed following one prior systemic therapy.The Fast Track program is intended to facilitate the development and expedite the review of drug candidates and vaccines that treat serious conditions and fill an unmet medical need. Programs with Fast Track designation may benefit from frequent communication with the FDA, in addition to a rolling submission of the marketing application.Presented new plasma DKK1 biomarker assay and results based on Part B of the DeFianCe study of sirexatamab plus bevacizumab and chemotherapy in colorectal cancer ("CRC") patients at the American Association for Cancer Research (AACR) 2026:At AACR 2026 in April, the Company presented a new plasma DKK1 biomarker assay that could be used as a companion diagnostic to select patients who would benefit from treatment with sirexatamab, the Company's anti-DKK1 monoclonal antibody.The new plasma DKK1 biomarker assay was used to test the patient samples from Part B of the DeFianCe study, a Phase 2 study of sirexatamab in combination with bevacizumab and chemotherapy compared to bevacizumab and chemotherapy in patients with microsatellite stable CRC who have received one prior systemic therapy for advanced disease.Sirexatamab demonstrated a statistically significant benefit on overall response rate ("ORR") and overall survival ("OS") in patients with high levels of DKK1 using the new plasma DKK1 biomarker assay.50% of patients had DKK1-high levels > 380 pg/ml, and in this subgroup of patients (n=87):ORR was 42% (including one complete response) in the Sirexatamab Arm vs. 16% ORR in the Control Arm, p-value = 0.003.mOS was not reached in the Sirexatamab Arm vs. 14.39 months in the Control Arm, HR 0.47, p-value = 0.0244.DKK1 plasma levels from patients in the DeFianCe study were similar to commercially acquired CRC patient samples.Selected First Quarter 2026 Financial ResultsNet loss was $77.2 million for the first quarter 2026, compared to $15.4 million for the first quarter of 2025. The increase was primarily due to unrealized losses on the fair value of the Company's ZEC treasury holdings which are marked to market at the end of each period. During the first quarter of 2026, the price of ZEC declined from $508.09 to $240.47.Research and development expenses were $0.2 million for the three months ended March 31, 2026, compared to $12.9 million for the same period in 2025. The decrease for the three months ended March 31, 2026 was primarily due to a decrease in clinical trial costs and manufacturing costs due to the completion of our clinical trials.General and administrative expenses were $4.7 million for the three months ended March 31, 2026, compared to $3.0 million for the same period in 2025. The increase for the three months ended March 31, 2026 was primarily due to an increase in stock-based compensation expense due to RSUs granted to employees and directors.During the three months ended March 31, 2026, the Company recorded a $77.6 million unrealized loss on the change in fair value of the Company's ZEC treasury holdings as the price of ZEC declined during the first quarter of 2026 from $508.09 to $240.47.Cash and cash equivalents totaled $6.7 million on March 31, 2026, and ZEC treasury holdings, categorized as digital asset receivable, totaled $73.8 million based on the ZEC price of $240.47 on March 31, 2026.About CypherpunkCypherpunk Technologies is a privacy technology company. The Company's mission is to advance technologies that guarantee privacy for humans on the internet. Cypherpunk pursues this mission through two primary strategies: accumulating Zcash (ZEC); and investing in, acquiring, and building technologies that push the frontier of privacy forward. Additionally, through its subsidiary Leap Therapeutics, the Company is developing novel therapies for patients with cancer, continuing the development of sirexatamab and FL-501. For more information about the Company, visit our websites at http://www.cypherpunk.com and http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov.About Winklevoss CapitalWinklevoss Capital is an investment firm founded in 2012 by Cameron and Tyler Winklevoss that invests in frontier technologies.FORWARD-LOOKING STATEMENTSThis press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. Forward-looking statements address various matters including statements relating to the value of the Company's ZEC holdings, the investment in ZODL, or digital assets held or to be held by the Company, the expected future market, price, and liquidity of ZEC or other digital assets the Company acquires, the macro and political conditions surrounding Zcash or digital assets, the Company's plan for value creation and strategic advantages, market size and growth opportunities, regulatory conditions, competitive position and the interest of other corporations in similar business strategies, technological and market trends, and future financial condition and performance. Risks and uncertainties of the digital asset treasury strategy include, among others: (a) risks relating to the Company's operations and business, including the highly volatile nature of the price of ZEC; (b) the risk that material changes in the price of ZEC, such as decreases in price, will result in significant changes to the Company's financial statements, such as unrealized losses on fair value of ZEC holdings and net loss; (c) the risk that the price of the Company's Common Stock may be highly correlated to the price of ZEC; (d) the risk that the Company will fail to realize the anticipated benefits of the ZEC digital asset treasury strategy or the investment in ZODL; (e) risks related to the custody of our ZEC and our reliance on Gemini Space Station and its affiliates for trading and custody services; (f) changes in business, market, financial, political and regulatory conditions; (g) risks related to increased competition in the industries in which the Company does and will operate; (h) risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; (i) risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; and (j) the ability to comply with the continued listing requirements of the Nasdaq Capital Market. With respect to our biotechnology operations, important factors that could cause actual results to differ materially from our plans, estimates or expectations could include, but are not limited to: (i) our ability and plan to develop and commercialize sirexatamab; (ii) our estimates regarding our capital requirements and our ability to raise additional financing to support continued development; (iii) the success of other competing therapies that may become available; (iv) the manufacturing capacity for sirexatmab; and (v) our ability to maintain and protect our intellectual property rights.New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. The Company may not actually achieve the forecasts disclosed in such forward-looking statements, and you should not place undue reliance on such forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties including but not limited to those set forth under the caption "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of potential risks, uncertainties, and other important factors in its subsequent filings with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Neither the Company, nor any of its affiliates, advisors or representatives, undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.Cypherpunk Technologies Inc.Consolidated Balance Sheets(in thousands, except share and per share amounts)


















March 31, 
December 31, 







2026
2025







(Unaudited)












Assets






Current assets:




Cash and cash equivalents
$           6,689
$         14,035
Digital assets receivable
73,849
147,404
Research and development incentive receivable
616
602
Prepaid expenses and other current assets
768
40




Total current assets
81,922
162,081











Right of use assets, net
38
38
Deferred costs
385
401
Deposits

33
662
Other investment
5,000
-




Total assets
$         87,378
$        163,182Liabilities and Stockholders' Equity 



Current liabilities:




Accounts payable
$              516
$           1,981
Accrued expenses
1,966
2,067
Income tax payable
483
472
Lease liability 
38
38




Total current liabilities
3,003
4,558










Non-current liabilities:




Deferred tax liability
-
5,118




Total liabilities
3,003
9,676










Stockholders' equity:




Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued
    and outstanding as of March 31, 2026 and December 31, 2025, respectively
-
-
Common stock, $0.001 par value; 490,000,000 shares authorized; 93,927,528 and 83,851,051
    shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
94
84
Stock subscription receivable
-
(150)
Additional paid-in capital
624,082
616,216
Accumulated other comprehensive loss
(86)
(95)
Accumulated deficit 
(539,715)
(462,549)




Total stockholders' equity 
84,375
153,506




Total liabilities and stockholders' equity 
$         87,378
$        163,182Cypherpunk Technologies Inc.Consolidated Statements of Operations(in thousands, except share and per share amounts)


















(Unaudited)







Three Months Ended March 31







2026
2025










Operating expenses:




Research and development
$                  161
$             12,911
General and administrative 
4,656
3,006


    Total operating expenses
4,817
15,917Loss from operations
(4,817)
(15,917)Interest income 
95
437Interest expense
(7)
(6)Australian research and development incentives
-
55Change in fair value of embedded derivative
(77,555)
-Foreign currency loss
-
(4)Loss before income taxes
(82,284)
(15,435)Benefit from income taxes
5,118
-Net loss attributable to common stockholders
$            (77,166)
$            (15,435)










Net loss per share 






Basic and Diluted
$               (0.46)
$               (0.37)










Weighted average common shares outstanding 






Basic and diluted
168,103,535
41,268,894 Cypherpunk Technologies Inc.  Condensed Consolidated Statements of Cash Flows  (in thousands) 


















 (Unaudited) 







 Three Months Ended March 31, 







2026
2025








 Cash used in operating activities 
$                (3,430)
$               (14,480) Cash used in investing activities 
(9,000)
- Cash provided by (used in) financing activities 
5,075
(61) Effect of exchange rate changes on cash and cash equivalents 
9
5 Net decrease in cash and cash equivalents 
(7,346)
(14,536) Cash and cash equivalents at beginning of period 
14,035
47,249 Cash and cash equivalents at end of period 
$                  6,689
$                32,713CONTACT:
Douglas E. Onsi
President & Chief Executive Officer
Cypherpunk Technologies Inc.
617-714-0360For Investors:Matthew DeYoung
Investor Relations
Argot Partners
212-600-1902
leap@argotpartners.comFor Media:Jacqueline Ortiz Ramsey
It Factor Strategies
954-294-3249
jacqueline@itfactorstrategies.com View original content to download multimedia:https://www.prnewswire.com/news-releases/cypherpunk-technologies-reports-first-quarter-2026-financial-results-302771640.htmlSOURCE Cypherpunk Technologies Inc. Original: Cypherpunk Technologies Reports First Quarter 2026 Financial Results

Is Zcash like buying bitcoin at $5,000?
If so, then CYPH like buying MSTR at $10?
Zcash has some interesting stuff.
Quantum resistant? Sounds good.
Cyph has to stop selling shares. It won’t run.
Time will tell.

CYPH.................................p/m

In just 4 Days zecash is now over 500! 
Go Cypherphunk! Go Zecash! 

Here’s the mathThey have 303,906 zeecash crypto which at a price per coin of 382. That yields a market cap of 115484000. Divided by 97.68 mil shares pps of 1.18 so 20% under valued

Risky hold a DAT so not investment advice 

Undervalued at the moment in my opinion based on ZEC crypto price 
Excited for Zcash crypto 

Cypherpunk Increases its Zcash Stake, Launches New Website and Investor DashboardApril 15, 2026 12:33 PM
PR Newswire (US)

CAMBRIDGE, Mass., April 15, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) today announced its latest purchase of 9,163.32 ZEC for $2,150,000 at an average purchase price of $234.63 per ZEC and launched its new website and investor dashboard at cypherpunk.com. Cypherpunk also notified investors that all future announcements regarding ZEC acquisitions and company updates will be made through the company's digital channels moving forward.New Zcash PurchaseThis new purchase brings Cypherpunk's total ZEC holdings to 303,906.40, at an average price of $332.83, bringing the company's total network ownership to 1.82%.New Website and DashboardThe newly launched website (cypherpunk.com) features a dedicated investor dashboard providing visibility into the company's key metrics, ZEC holdings, and other privacy investments along with Zcash network metrics. The dashboard is designed to give shareholders direct access to the information that matters most to Cypherpunk's investor base.Future Disclosure ChannelsConsistent with its commitment to transparency and direct communication with shareholders, Cypherpunk will announce future ZEC acquisitions, updates, and other material non-public developments through the following channels:Website: cypherpunk.comX: @cypherpunkLinkedIn: https://www.linkedin.com/company/cypherpunk-technologies-inc/SEC Filings: Available via EDGAR at sec.gov and the Investors section of cypherpunk.comThe content of Cypherpunk's website and information that Cypherpunk may post on social media channels, including those mentioned above, are not incorporated by reference into any report or document the Company files with the Securities and Exchange Commission, and any references to the Company's website or these social media channels are intended to be inactive textual references only. Investors are encouraged to follow these channels and enable notifications to stay current with company updates. This press release marks the final time the company will use a traditional wire release for routine ZEC treasury announcements.About CypherpunkCypherpunk Technologies is a privacy technology company. The Company's mission is to advance technologies that guarantee privacy for humans on the internet. Cypherpunk pursues this mission through two primary strategies: accumulating Zcash (ZEC); and investing in, acquiring, and building technologies that push the frontier of privacy forward. Additionally, through its subsidiary Leap Therapeutics, Inc., the Company is developing novel therapies for patients with cancer, continuing the development of sirexatamab and FL-501. For more information about the Company, visit our websites at http://www.cypherpunk.com and http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov.About Winklevoss CapitalWinklevoss Capital is an investment firm founded in 2012 by Cameron and Tyler Winklevoss that invests in frontier technologies.FORWARD-LOOKING STATEMENTSThis press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. Forward-looking statements address various matters including statements relating to ZEC held by the Company, the expected future market, price and liquidity of ZEC, the macro and political conditions surrounding Zcash or digital assets, the Company's plan for value creation and strategic advantages, market size and growth opportunities, regulatory conditions, competitive position, technological and market trends, and future financial condition and performance. Risks and uncertainties of the Company's strategy include, among others: (a) risks relating to the Company's operations and business, including the highly volatile nature of the price of cryptocurrencies, including ZEC; (b) the risk that the price of the Company's Common Stock may be highly correlated to the price of ZEC; (c) risks related to increased competition in the industries in which the Company does and will operate; (d) risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; (e) risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; and (f) the ability to comply with the continued listing requirements of the Nasdaq Capital Market. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. The Company may not actually achieve the forecasts disclosed in such forward-looking statements, and you should not place undue reliance on such forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties including but not limited to those set forth under the caption "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of potential risks, uncertainties, and other important factors in its subsequent filings with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Neither the Company, nor any of its affiliates, advisors or representatives, undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.CONTACT: Douglas E. Onsi
President & Chief Executive Officer
Cypherpunk Technologies Inc.
617-714-0360For Investors:
Matthew DeYoung
Investor Relations
Argot Partners
212-600-1902
leap@argotpartners.comFor Media:
Jacqueline Ortiz Ramsey
It Factor Strategies
954-294-3249
jacqueline@itfactorstrategies.comLogo - https://mma.prnewswire.com/media/2820582/Cypherpunk_Logo.jpg



View original content:https://www.prnewswire.co.uk/news-releases/cypherpunk-increases-its-zcash-stake-launches-new-website-and-investor-dashboard-302743515.html

Original: Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard

Cypherpunk Increases its Zcash Stake, Launches New Website and Investor DashboardApril 15, 2026 12:21 PM
PR Newswire (US)

CAMBRIDGE, Mass., April 15, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) today announced its latest purchase of 9,163.32 ZEC for $2,150,000 at an average purchase price of $234.63 per ZEC and launched its new website and investor dashboard at cypherpunk.com. Cypherpunk also notified investors that all future announcements regarding ZEC acquisitions and company updates will be made through the company's digital channels moving forward.New Zcash PurchaseThis new purchase brings Cypherpunk's total ZEC holdings to 303,906.40, at an average price of $332.83, bringing the company's total network ownership to 1.82%.New Website and DashboardThe newly launched website (cypherpunk.com) features a dedicated investor dashboard providing visibility into the company's key metrics, ZEC holdings, and other privacy investments along with Zcash network metrics. The dashboard is designed to give shareholders direct access to the information that matters most to Cypherpunk's investor base.Future Disclosure ChannelsConsistent with its commitment to transparency and direct communication with shareholders, Cypherpunk will announce future ZEC acquisitions, updates, and other material non-public developments through the following channels:Website: cypherpunk.comX: @cypherpunkLinkedIn: https://www.linkedin.com/company/cypherpunk-technologies-inc/SEC Filings: Available via EDGAR at sec.gov and the Investors section of cypherpunk.comThe content of Cypherpunk's website and information that Cypherpunk may post on social media channels, including those mentioned above, are not incorporated by reference into any report or document the Company files with the Securities and Exchange Commission, and any references to the Company's website or these social media channels are intended to be inactive textual references only. Investors are encouraged to follow these channels and enable notifications to stay current with company updates. This press release marks the final time the company will use a traditional wire release for routine ZEC treasury announcements.About CypherpunkCypherpunk Technologies is a privacy technology company. The Company's mission is to advance technologies that guarantee privacy for humans on the internet. Cypherpunk pursues this mission through two primary strategies: accumulating Zcash (ZEC); and investing in, acquiring, and building technologies that push the frontier of privacy forward. Additionally, through its subsidiary Leap Therapeutics, Inc., the Company is developing novel therapies for patients with cancer, continuing the development of sirexatamab and FL-501. For more information about the Company, visit our websites at http://www.cypherpunk.com and http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov.About Winklevoss CapitalWinklevoss Capital is an investment firm founded in 2012 by Cameron and Tyler Winklevoss that invests in frontier technologies.FORWARD-LOOKING STATEMENTSThis press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. Forward-looking statements address various matters including statements relating to ZEC held by the Company, the expected future market, price and liquidity of ZEC, the macro and political conditions surrounding Zcash or digital assets, the Company's plan for value creation and strategic advantages, market size and growth opportunities, regulatory conditions, competitive position, technological and market trends, and future financial condition and performance. Risks and uncertainties of the Company's strategy include, among others: (a) risks relating to the Company's operations and business, including the highly volatile nature of the price of cryptocurrencies, including ZEC; (b) the risk that the price of the Company's Common Stock may be highly correlated to the price of ZEC; (c) risks related to increased competition in the industries in which the Company does and will operate; (d) risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; (e) risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; and (f) the ability to comply with the continued listing requirements of the Nasdaq Capital Market. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. The Company may not actually achieve the forecasts disclosed in such forward-looking statements, and you should not place undue reliance on such forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties including but not limited to those set forth under the caption "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of potential risks, uncertainties, and other important factors in its subsequent filings with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Neither the Company, nor any of its affiliates, advisors or representatives, undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.CONTACT: Douglas E. Onsi
President & Chief Executive Officer
Cypherpunk Technologies Inc.
617-714-0360For Investors:
Matthew DeYoung
Investor Relations
Argot Partners
212-600-1902
leap@argotpartners.comFor Media:
Jacqueline Ortiz Ramsey
It Factor Strategies
954-294-3249
jacqueline@itfactorstrategies.com





View original content to download multimedia:https://www.prnewswire.com/news-releases/cypherpunk-increases-its-zcash-stake-launches-new-website-and-investor-dashboard-302743497.htmlSOURCE Cypherpunk Technologies Inc.

Original: Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard

CYPH...................................p/m

Cypherpunk Reports Full Year 2025 Financial ResultsMarch 16, 2026 4:50 PM
PR Newswire (US)

CAMBRIDGE, Mass., March 16, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the year ended December 31, 2025."2025 was a transformational year. Following a $58.88 million private placement led by Winklevoss Capital, we rebranded as Cypherpunk to become a privacy technology company with a digital asset treasury strategy focused on Zcash, while advancing sirexatamab for the treatment of patients with colorectal cancer through our Leap Therapeutics subsidiary," said Douglas E. Onsi, President and CEO of Cypherpunk."Since we began operating as Cypherpunk in October, we have purchased 294,743.10 ZEC for our treasury and made a $5 million strategic investment in Zcash Open Development Lab ("ZODL"), the development team behind Zodl, the leading Zcash wallet. In the year ahead, we will remain focused on advancing the adoption of Zcash and expanding our efforts across a broad set of technologies that defend privacy," said Will McEvoy, Chief Investment Officer of Cypherpunk.Cypherpunk Highlights:Closed a $58.88 million private placement in cash led by Winklevoss CapitalIn October 2025, the Company raised $58,888,888 in cash led by Winklevoss Capital to become the leading public company focused on advancing privacy preserving technologies. In the transaction, the Company issued: (i) 15,212,311 shares of common stock, (ii) pre-funded warrants to purchase up to an aggregate of 80,768,504 shares of common stock at an exercise price of $0.001 per share, and (iii) warrants to purchase an additional 71,985,605 shares of common stock at an exercise price of $0.5335 per share.    Appointed digital asset executives and industry leaders as board members and strategic advisorsIn November 2025, the Company appointed Khing Oei as Chairman of the Board of Directors, and Will McEvoy as Chief Investment Officer and a Board member.In December 2025, the Company announced that industry pioneer Zooko Wilcox, the founder of Zcash, former CEO of the Electric Coin Company, and current Chief Product Officer of Shielded Labs, joined the company as a Strategic Advisor.In December 2025, the Company announced that Josh Swihart, Chief Executive Officer of ZODL, joined the company as a Strategic Advisor.In January 2026, the Company announced that Arjun Khemani, a prominent voice in the Zcash ecosystem and the "philosophy of progress" movement, joined the company as a Strategic Advisor.Increased treasury holdings to 294,743.10 ZECAs of March 12, 2026, Cypherpunk holds a total of 294,743.10 ZEC, at an average purchase price of $335.89, representing approximately 1.78% of the total circulating supply of the Zcash network.The Company believes that privacy-protecting assets and related technologies will be critical in the increasingly digital and AI driven world. The Company intends to acquire and hold ZEC, the native coin of Zcash, as its primary digital asset and to be an active participant in the Zcash community.ZEC is a digital currency that can be transmitted over a peer-to-peer payment system. Zcash uses a cryptographic method called "zero-knowledge proofs" to allow users to engage in financial transactions while maintaining greater privacy.Invested $5 million into ZODLIn March 2026, the Company expanded its holdings with a $5 million investment in Zcash company, ZODL, alongside key investors including a16z, Winklevoss Capital, Coinbase, Paradigm, Chapter One, David Friedberg, Balaji Srinivasan, and others. This marks Cypherpunk's first technology investment outside of ZEC. ZODL, which now houses the top Zcash wallet, Zodl, aims to make Zcash easier to use with continued development of the wallet and support of the Zcash protocol.Leap Therapeutics Subsidiary Highlights:Presented final clinical data from Part B of the DeFianCe study of sirexatamab plus bevacizumab and chemotherapy in colorectal cancer ("CRC") patientsIn a Mini Oral session at the ESMO Congress in October 2025, the Company presented the final results from Part B of the DeFianCe study, a Phase 2 study of sirexatamab, an anti-DKK1 monoclonal antibody, in combination with bevacizumab and chemotherapy compared to bevacizumab and chemotherapy in patients with microsatellite stable CRC who have received one prior systemic therapy for advanced disease. Sirexatamab demonstrated a statistically significant benefit on overall response rate ("ORR"), progression-free survival ("PFS"), and Overall Survival ("OS") in patients with high levels of DKK1, along with a positive trend on ORR and PFS in the full intent-to-treat population.Across the DKK1-high (upper quartile) patients (n=44):ORR was 44.0% in the Sirexatamab Arm vs. 15.8% ORR in the Control Arm,
p-value = 0.0149.mPFS was 9.36 months in the Sirexatamab Arm vs. 5.88 months in the Control Arm, HR 0.46, p-value = 0.0168.mOS was not reached in the Sirexatamab Arm vs. 9.66 months in the Control Arm, HR 0.17, p-value < 0.001.Advancing DKK1 biomarker diagnostic test and engaging with regulatory authoritiesLeap is engaging with regulatory agencies to discuss the registrational pathway for sirexatamab in DKK1-high CRC patients. Leap is also working with a leading diagnostics research laboratory to optimize the DKK1 biomarker diagnostic test that could be used to identify DKK1-high CRC patients with poor prognosis and to select patients for treatment with sirexatamab. Leap expects to provide an update on the next steps in sirexatamab development and on the registrational pathway in the coming weeks.Selected Year-End 2025 Financial Results Net Income was $4.8 million for the year ended December 31, 2025, compared to a Net Loss of $67.8 million for the year ended December 31, 2024. The increase was primarily due to $50.4 million of unrealized gains on the fair value of the Company's ZEC treasury holdings which are marked to market at the end of each period, as well reductions in research and development expenses and general and administrative expenses due to the completion of the sirexatamab Phase 2 clinical development program and a reduction in force of full-time employees.Research and development expenses were $25.7 million for the full year 2025, compared to $57.2 million for the same period in 2024. The decrease for the full year 2025 was primarily due to a decrease in clinical trial costs and manufacturing costs during the year ended December 31, 2025. There was also a decrease in payroll and other related expenses due to a decrease in headcount, a decrease in stock based compensation expense, and a decrease in consulting fees.General and administrative expenses were $10.9 million for the full year 2025, compared to $12.8 million for the same period in 2024. The decrease for the full year 2025 was primarily due to a decrease in payroll and other related expenses due to a decrease in incentive based compensation expense and a decrease in headcount. This decrease was partially offset by an increase in stock based compensation expense due to RSUs granted, and an increase in professional fees during the year ended December 31, 2025. During the year ended December 31, 2025, the Company recorded a $50.4 million unrealized gain on the change in fair value of the Company's ZEC treasury holdings.Cash and cash equivalents totaled $14.0 million on December 31, 2025, and ZEC treasury holdings, categorized as a digital asset receivable, totaled $147.4 million on December 31, 2025.About CypherpunkCypherpunk Technologies is a privacy technology company. The Company's mission is to advance technologies that guarantee privacy for humans on the internet. Cypherpunk pursues this mission through two primary strategies: accumulating Zcash (ZEC); and investing in, acquiring, and building technologies that push the frontier of privacy forward. Additionally, through its subsidiary Leap Therapeutics, Inc., the Company is developing novel therapies for patients with cancer, continuing the development of sirexatamab and FL-501. For more information about the Company, visit our websites at http://www.cypherpunk.com and http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via https://investors.leaptx.com/. About Winklevoss CapitalWinklevoss Capital is an investment firm founded in 2012 by Cameron and Tyler Winklevoss that invests in frontier technologies.FORWARD-LOOKING STATEMENTSThis press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. Forward-looking statements address various matters including statements relating to the value of the Company's ZEC holdings, the investment in ZODL, or digital assets held or to be held by the Company, the expected future market, price, and liquidity of ZEC or other digital assets the Company acquires, the macro and political conditions surrounding Zcash or digital assets, the Company's plan for value creation and strategic advantages, market size and growth opportunities, regulatory conditions, competitive position and the interest of other corporations in similar business strategies, technological and market trends, and future financial condition and performance. Risks and uncertainties of the digital asset treasury strategy include, among others: (a) risks relating to the Company's operations and business, including the highly volatile nature of the price of ZEC; (b) the risk that material changes in the price of ZEC, such as decreases in price, will result in significant changes to the Company's financial statements, such as unrealized losses on fair value of ZEC holdings and net loss; (c) the risk that the price of the Company's Common Stock may be highly correlated to the price of ZEC; (d) the risk that the Company will fail to realize the anticipated benefits of the ZEC digital asset treasury strategy or the investment in ZODL; (e) risks related to the custody of our ZEC and our reliance on Gemini Space Station and its affiliates for trading and custody services; (f) changes in business, market, financial, political and regulatory conditions; (g) risks related to increased competition in the industries in which the Company does and will operate; (h) risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; (i) risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; and (j) the ability to comply with the continued listing requirements of the Nasdaq Capital Market. With respect to our biotechnology operations, important factors that could cause actual results to differ materially from our plans, estimates or expectations could include, but are not limited to: (i) our ability and plan to develop and commercialize sirexatamab; (ii) our estimates regarding our capital requirements and our ability to raise additional financing to support continued development; (iii) the success of other competing therapies that may become available; (iv) the manufacturing capacity for sirexatmab; and (v) our ability to maintain and protect our intellectual property rights.New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. The Company may not actually achieve the forecasts disclosed in such forward-looking statements, and you should not place undue reliance on such forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties including but not limited to those set forth under the caption "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of potential risks, uncertainties, and other important factors in its subsequent filings with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Neither the Company, nor any of its affiliates, advisors or representatives, undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.CONTACT: Douglas E. Onsi
President & Chief Executive Officer
Cypherpunk Technologies Inc.
617-714-0360For Investors:
Matthew DeYoung
Investor Relations
Argot Partners
212-600-1902
leap@argotpartners.comFor Media:
Jacqueline Ortiz Ramsey
It Factor Strategies
954-294-3249
jacqueline@itfactorstrategies.com Cypherpunk Technologies, IncConsolidated Statement of Operations
(in thousands, except share and per share amounts)









Year Ended December 31







2025
2024










Operating expenses:




Research and development
$              25,670
$            57,211
General and administrative 
10,870
12,846
Restructuring charges
4,527
-


    Total operating expenses
41,067
70,057Loss from operations
(41,067)
(70,057)Interest income 
916
3,129Interest expense
(24)
-Australian research and development incentives
(157)
-Change in fair value of digital assets
50,404
-Foreign currency gain (loss)
5
(42)Income (loss) before income taxes 
10,077
(66,970)Provision for income taxes
(5,255)
(585)Net income (loss)   
4,822
(67,555)Dividend attributable to down round feature of warrants
-
(234)Net income (loss) attributable to common stockholders
$                4,822
$          (67,789)





















Net income (loss) per share 






Basic   
$                  0.07
$              (1.81)


Diluted
$                  0.07
$              (1.81)










Weighted average common shares outstanding 






Basic   
66,140,346
37,550,677


Diluted
70,672,358
37,550,677 Cypherpunk Technologies, IncConsolidated Balance Sheets
(in thousands, except share and per share amounts)









December 31, 







2025
2024










Assets






Current assets:




Cash and cash equivalents
$          14,035
$          47,249
Digital assets receivable
147,404
-
Research and development incentive receivable
602
704
Prepaid expenses and other current assets
40
86




Total current assets
162,081
48,039











Right of use assets, net
38
262
Deferred costs
401
-
Deposits

662
823




Total assets
$        163,182
$          49,124










Liabilities and Stockholders' Equity 



Current liabilities:




Accounts payable
$            1,981
$            4,743
Accrued expenses
2,067
8,536
Income tax payable
472
531
Lease liability 
38
266




Total current liabilities
4,558
14,076










Non-current liabilities:




Deferred tax liability
5,118
-




Total liabilities
9,676
14,076










Stockholders' equity:




Preferred stock, $0.001 par value; 10,000,000 shares authorized; 
    0 shares issued and outstanding as of December 31, 2025 and
    2024, respectively
-
-
Common stock, $0.001 par value; 490,000,000  and 240,000,000 shares
    authorized;  83,851,051 and 38,329,894 shares issued and outstanding
    as of December 31, 2025 and 2024, respectively
84
38
Stock subscription receivable
(150)
-
Additional paid-in capital
616,216
502,501
Accumulated other comprehensive loss
(95)
(120)
Accumulated deficit 
(462,549)
(467,371)




Total stockholders' equity 
153,506
35,048




Total liabilities and stockholders' equity 
$        163,182
$          49,124 Cypherpunk Technologies, IncCondensed Consolidated Statements of Cash Flows
(in thousands)








 Year Ended December 31, 







2025
2024








 Cash used in operating activities 
$                  (43,902)
$                 (60,299) Cash used in investing activities 
(97,000)
- Cash provided by financing activities 
107,649
37,184 Effect of exchange rate changes on cash and cash equivalents 
39
(279) Net decrease in cash and cash equivalents 
$                  (33,214)
$                 (23,394) Cash and cash equivalents at beginning of year 
47,249
70,643 Cash and cash equivalents at end of year 
$                   14,035
$                  47,249  





View original content to download multimedia:https://www.prnewswire.com/news-releases/cypherpunk-reports-full-year-2025-financial-results-302715122.htmlSOURCE Cypherpunk Technologies Inc.

Original: Cypherpunk Reports Full Year 2025 Financial Results

Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL)March 9, 2026 9:20 AM
PR Newswire (US)

Cypherpunk expands its holdings with new $5M investment in Zcash company, ZODL, alongside key investors including a16z, Winklevoss Capital, Coinbase, Paradigm, Chapter One, David Friedberg, Balaji Srinivasan, and othersCAMBRIDGE, Mass., March 9, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) today announced the company has invested $5M into Zcash Open Development Lab (ZODL) marking its first technology investment outside of ZEC. ZODL was founded and is led by former Electric Coin Company (ECC) CEO Josh Swihart.At ECC, Josh and his team, who have joined him at ZODL, launched the top Zcash wallet, Zashi, now rebranded to Zodl. Zashi was arguably the single biggest factor responsible for putting Zcash back on the map last year. In particular, its simple UX allowed for the Orchard shielded pool to grow from ~1M ZEC to ~4M ZEC during the span of 2025.ZODL, which now houses the Zashi wallet technology and related intellectual property, aims to make Zcash easier to use with continued development of the wallet, as well as supporting Zcash at the protocol level.The new investment strongly aligns with Cypherpunk's mission of advancing technologies that guarantee privacy for all humans on the internet and gives its shareholders exposure to a private company building critical privacy infrastructure on the frontier."True to their name, Cypherpunk is backing the builders who will put shielded ZEC in the hands of billions. We're grateful for their support and proud to partner with them in bringing private digital money to the global mainstream." – Josh Swihart, CEO of ZODLThe investment in ZODL is highly synergistic with Cypherpunk's ZEC treasury."As ZODL makes Zcash easier to use, we expect adoption of the protocol to grow alongside demand for ZEC." – Cameron and Tyler WinklevossSwihart joined Cypherpunk in December as a strategic advisor. Cypherpunk's current total ZEC holdings stand at 294,743.10, at an average price of $335.89, bringing the company's total network ownership to ~1.78%."ZODL and Cypherpunk are the two most important companies in privacy. We're excited to embark together on this mission of accelerating technology that defends self-sovereignty and secures human freedom." – Will McEvoy, Chief Investment Officer of CypherpunkAbout CypherpunkCypherpunk Technologies Inc. is a privacy technology company implementing a digital asset treasury strategy anchored by Zcash and, through its subsidiary Leap Therapeutics, Inc., is developing novel therapies for patients with cancer. The Company is aiming to build long-term shareholder value by acquiring ZEC, participating in the development of privacy technologies and Zcash, and continuing the development of sirexatamab and FL-501 to treat patients with cancer. For more information about the Company, visit our websites at http://www.cypherpunk.com and http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via https://investors.leaptx.com/.About Winklevoss CapitalWinklevoss Capital is an investment firm founded in 2012 by Cameron and Tyler Winklevoss that invests in frontier technologies.FORWARD-LOOKING STATEMENTS
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. Forward-looking statements address various matters including statements relating to the investment in Zcash Open Development Lab ("ZODL"), ZEC, or digital assets held or to be held by the Company, the expected future market, price and liquidity of ZEC or other digital assets the Company acquires, the macro and political conditions surrounding Zcash or digital assets, the Company's plan for value creation and strategic advantages, market size and growth opportunities, regulatory conditions, competitive position and the interest of other corporations in similar business strategies, technological and market trends, and future financial condition and performance. Risks and uncertainties of the digital asset treasury strategy include, among others: (a) the risk that the Company will fail to realize the anticipated benefits of the investment in ZODL and the digital asset treasury strategy; (b) changes in business, market, financial, political and regulatory conditions; (c) risks relating to the Company's operations and business, including the highly volatile nature of the price of cryptocurrencies, including ZEC; (d) the risk that the price of the Company's Common Stock may be highly correlated to the price of ZEC or other digital assets that it holds; (e) risks related to increased competition in the industries in which the Company does and will operate; (f) risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; and (g) risks relating to the treatment of crypto assets for U.S. and foreign tax purposes. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. The Company may not actually achieve the forecasts disclosed in such forward-looking statements, and you should not place undue reliance on such forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties including but not limited to those set forth under the caption "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of potential risks, uncertainties, and other important factors in its subsequent filings with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Neither the Company, nor any of its affiliates, advisors or representatives, undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.CONTACT:Douglas E. Onsi
President & Chief Executive Officer
Cypherpunk Technologies Inc.
617-714-0360
ir@cypherpunk.com For Media:
Jacqueline Ortiz Ramsay
It Factor Strategies
954-294-3249
jacqueline@itfactorstrategies.com For Investors:
Matthew DeYoung
Investor Relations
Argot Partners
212-600-1902
leap@argotpartners.comLogo - https://mma.prnewswire.com/media/2928741/cypherpunk_Logo.jpg 



View original content:https://www.prnewswire.co.uk/news-releases/cypherpunk-makes-5m-investment-into-zcash-open-development-lab-zodl-302708170.html

Original: Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL)

I got out of this position long time ago and took a loss.

Whelp, ZEC surely is in the sewer --for the time being.

cyph.................................................p/m

Great News for CYPH on 12/19/25,Click on link https://investorshub.advfn.com/stock-market/NASDAQ/cypherpunk-technologies-CYPH/stock-news/97482238/josh-swihart-ecc-ceo-joins-cypherpunk-as-strateg

CYPH..........................................https://stockcharts.com/sc3/ui/?s=CYPH&p=W&b=5&g=0&id=p86431144783

$10+ coming 

Be Happy. There's New Beginning!

Ready for the jump!

https://www.perplexity.ai/finance/ZECUSDDec 2 at 9:32:45 AM EST

ZEC at 332 

https://www.perplexity.ai/finance/ZECUSDDec 2 at 9:31:58 AM EST

Back in $1.20s for a flip...
Cypherpunk Technologies purchased 29,869 ZEC for $18 mln at an average price of $602.63, increasing its total holdings to 233,644 ZEC at an average cost of $291.04.The company now controls 1.43% of the Zcash network, following its earlier $50 mln acquisition of 203,775 ZEC.Recent governance updates include adding investor Khing Oei to the Board and naming Will McEvoy of Winklevoss Capital as both Board member and Chief Investment Officer.Cypherpunk frames Zcash as a form of digital privacy, positioning it as a hedge against transparency in traditional finance and an essential asset in an AI-driven future where privacy becomes increasingly scarce.

Grayscale ETF news today is great for us!!

MFI had much better news than RELI

I know, it can be either or.

r/s or 500m a/s is the decision point for them after December 15th per the adjusted Warrants. If ZEC takes off 500m is an after thought. r/s IMO only if they have to, will they do it.

The only way this moves up is ZEC, I keep averaging down. It's been bleeding all week with occasional spikes. Nothing I can do but to hold and average down until ZEC is over 1000 at some point and see how it plays out.

Yikes market Not liking us yet 

Thanks Deano.

https://finance.yahoo.com/news/exclusive-reliance-global-moves-digital-130022237.html

Sitting 14800 shares now, it filled the gap between 1.80-1.90. Hopefully by tomorrow we will know if the brothers bought a boat load of ZEC. I am not going anywhere with this one, this will play out nicely.

This is a very good one to hold for good gains, once ZEC is over 1000 and 2000 dollars early to mid next year.

Thank you for sharing dino!!!
Love this opportunity.
CYPH

ZEC will be trading in China tomorrow, where Bitcoin and other cryptos are banned. Massive run tomorrow, first stop 5 dollars then on its way to 10 dollars, just hope the brother bought at least 50,000 ZEC on the last drop, that news hits tomorrow or the next day, by Christmas this will be over 10 easily.

CYPH is going to see the teens once ZEC hits 1000 dollars by year end. The savvy crypto traders are already eyeballing ZEC, a hedge funds stated in one article that ZEC can easily hit 10,000 dollars mark and Fidelity stated in one article that ZEC can essentially hit 100,000 mark year end 2028. Once everyone notices the that is hitting 1000 dollars big players will pile in, no one wanted Bitcoin at 800 and suddenly everyone wanted a piece of it at 5000 and next thing you over 150,000 dollars at one point over a month ago. ZEC will be top tier crypto soon enough.

Trying to put a value on CYPH if by end 2026 if ZEC is going to hit 10% valuation of Bitcoin, it seems most hedges will dump Bitcoin and rotate their funds into ZEC. They are guesstimating ZEC to be around 260 billion by year end 2026 that will put the valuation of CYPH somewhere in the range 10 billion if my math is correct. I am going to add what I can when I can anything under $3.00. Good luck Deano

$20 may be in the cards for intraday jump before end of year. I am watching the filings. The Wink boys moving their warrant options constantly LOL ! We are on Reg Sho, etc.. Seems alot of activity. They will max out sell all of A/S of 240m shares by Dec 15th vote and buy more ZEC. Not necessarily max out the o/s to the a/s. Then vote in Dec for 500 a/s. Even with 500m a/s and we get to $thousands for ZEC we still can see $10+

CYPH is going to run big next week. Getting in early Monday. ZCASH 4000-5000 end of next year.

ZCASH was on CNBC. CYPH will do really well in the coming months. Looking to add early next week again.

I believe CYPH will buy another load within a week or two.

"There is no evidence that the government of Switzerland or the Swiss National Bank is planning to invest in Zcash (ZEC). Recent news indicates that the Swiss government plans to make significant direct investments in the United States, but not in any specific cryptocurrency.
However, the Swiss "Crypto Valley" is a hub for blockchain innovation and is home to several private companies and initiatives that work with Zcash technology:
Centi: A Swiss company is implementing the first large-scale commercial deployment of Zcash Shielded Assets (ZSA) for loyalty tokens, vouchers, and their stablecoin, the Centi Franc. This allows merchants to accept digital payments while maintaining transaction privacy, similar to cash.
Shielded Labs: This is an independent, donation-funded Zcash support organization based in Switzerland.
Institutional interest: The Swiss stock exchange SIX is exploring a new crypto trading platform aimed at institutional investors, leveraging Switzerland's clear crypto regulations. Grayscale, a major digital asset manager, has previously highlighted Zcash as a potentially significant asset for privatized wealth storage, comparing its privacy features to those of a "Swiss bank account in your pocket".
Regulatory environment: Switzerland has a clear and favorable legal framework for cryptocurrencies and blockchain technology, overseen by the financial regulator FINMA.
In summary, private Swiss entities are actively involved in the Zcash ecosystem, but there are no plans for a direct investment by the Swiss government itself."

People still don't get this, they are flipping this a nickel at at time, it won't take much to move ZEC, in-fact it can move 50% to the upside in blink of an eye and when that happens, look for CYPH move very rapidly and break out of single digits in multiple days.

Yes it's quite a gold mine here we have